Neurodegeneration with Brain Iron Accumulation Disorders and Retinal Neurovascular Structure

Abstract

AbstractBackgroundThe unique neurovascular structure of the retina has provided an opportunity to observe brain pathology in many neurological disorders. However, such studies on neurodegeneration with brain iron accumulation (NBIA) disorders are lacking.ObjectivesTo investigate NBIA's neurological and ophthalmological manifestations.MethodsThis cross‐sectional study was conducted on genetically confirmed NBIA patients and an age‐gender‐matched control group. The thickness of retinal layers, central choroidal thickness (CCT), and capillary plexus densities were measured by spectral domain‐optical coherence tomography (SD‐OCT) and OCT angiography, respectively. The patients also underwent funduscopy, electroretinography (ERG), visual evoked potential (VEP), and neurological examination (Pantothenate‐Kinase Associated Neurodegeneration‐Disease Rating Scale [PKAN‐DRS]). The generalized estimating equation model was used to consider inter‐eye correlations.ResultsSeventy‐four patients' and 80 controls' eyes were analyzed. Patients had significantly decreased visual acuity, reduced inner or outer sectors of almost all evaluated layers, increased CCT, and decreased vessel densities, with abnormal VEP and ERG in 32.4% and 45.9%, respectively. There were correlations between visual acuity and temporal peripapillary nerve fiber layer (positive) and between PKAN‐DRS score and disease duration (negative), and scotopic b‐wave amplitudes (positive). When considering only the PKAN eyes, ONL was among the significantly decreased retinal layers, with no differences in retinal vessel densities. Evidence of pachychoroid was only seen in patients with Kufor Rakeb syndrome.ConclusionObserving pathologic structural and functional neurovascular changes in NBIA patients may provide an opportunity to elucidate the underlying mechanisms and differential retinal biomarkers in NBIA subtypes in further investigations. © 2023 International Parkinson and Movement Disorder Society.